Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017

Abstract Background Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients on opioid agonist therapy (OAT) are common and have pros and cons. The objectives of the current study are to define the dispensation rates of these potentially addictive drugs, and whether the number a...

Full description

Bibliographic Details
Main Authors: Jørn Henrik Vold, Svetlana Skurtveit, Christer Aas, Fatemeh Chalabianloo, Pia Synnøve Kloster, Kjell Arne Johansson, Lars Thore Fadnes
Format: Article
Language:English
Published: BMC 2020-04-01
Series:BMC Health Services Research
Subjects:
Opioid substitution treatment
Benzodiazepines
Zopiclone
Zolpidem
Pregabalin
Gabapentin
Online Access:http://link.springer.com/article/10.1186/s12913-020-05195-5

Internet

http://link.springer.com/article/10.1186/s12913-020-05195-5

Similar Items